Intensive Care: Clinical Trials

4 trials for Intensive Care, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Unknown 2, Active not recruiting 1, Terminated 1

Follow Intensive Care: new trials by email Literature Review of Intensive Care trials Research Report on Intensive Care

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The PASTDUe Nutrition Ecosystem Project (PASTDUe)
Nutrition Ecosystem pathway, Comparator - Diet, Healthy, Food
Phase 4Active not recruitingDuke University3002022-04-252026-04-23
Ketamine and Refractory Painful Care in a Palliative Unit
Ketamine - Intractable Pain, Intensive Care
Phase 4TerminatedLille Catholic University82016-05-012020-03-03
The Pharmacokinetics of Fentanyl in Intensive Care Patients
Fentanyl - Multiple Organ Failure, Critical Care
Phase 4UnknownOslo University Hospital1502015-10-012015-10-29
Effect of Daily Nicotine Patch Application on Mechanical Ventilation Weaning in Smoking Patients
Nicotine patch, Placebo - Smoking, Mechanical Ventilation
Phase 4UnknownUniversity of Paris 5 - Rene Descartes6002010-01-012010-04-16

Narrower conditions

Abdominal Injuries (1)  ·  Agnosia (1)  ·  Intraabdominal Infections (1)  ·  Multiple Organ Failure (1)  ·  Pain, Intractable (1)  ·  Pressure Ulcer (1)  ·  Sepsis (1)  ·  Smoking (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Pathologic Processes (2)  ·  Behavior (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Perceptual Disorders (1)  ·  Shock (1)  ·  Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin Ulcer (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Fentanyl (1)  ·  Ketamine (1)  ·  Nicotine Chewing Gum (1)  ·  Tobacco Use Cessation Devices (1)

Sponsors

Duke University (1)  ·  Lille Catholic University (1)  ·  Oslo University Hospital (1)  ·  University of Paris 5 - Rene Descartes (1)

Countries

France (2)  ·  Norway (1)  ·  United States (1)

Top investigators

Didier Journois, M.D. Ph.D. (1)  ·  Marie Danel Delerue, MD (1)  ·  Paul Wischmeyer (1)  ·  Tom Heier, Professor (1)